awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35285011-2B8CFF73-57AB-4277-9D6E-833D00F6714D
Q35285011-2B8CFF73-57AB-4277-9D6E-833D00F6714D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-2B8CFF73-57AB-4277-9D6E-833D00F6714D
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.
P2860
Q35285011-2B8CFF73-57AB-4277-9D6E-833D00F6714D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-2B8CFF73-57AB-4277-9D6E-833D00F6714D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ce860f9b629b2632ab831d84c0ac8ed697cb672
P2860
Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.